Clinical Evidence Reveals Unique Biological Response to Trabecular Metal™ Dental Implant
July 9, 2019 by Implant Practice Team
Mounting Studies Support Implant Therapy for Previously Untreatable Patients
(PALM BEACH GARDENS, Fla.) July 2nd, 2019—Zimmer Biomet has released a clinical compendium demonstrating evidence of the BioBoost Effect™, a novel reproducible biological effect following placement of Trabecular Metal dental implants that evidences the acceleration of bone growth, vascularization and wound healing. Several clinical publications demonstrate a multiplication of naturally occurring growth factors that deliver faster healing and earlier bone formation than traditional implants.1 The discovery of the BioBoost Effect has expanded treatment options for dental patients who, until recently, may not have been viable candidates for dental implant therapy.
"The Trabecular Metal Implant in rapid recovery protocol has been a game-changer for our practice," said Jason Kennedy, DMD. "We can we take a patient from an edentulous state to a final restoration in two weeks' time."
The new compendium summarizes highlights from 30 clinical publications, documenting immediate and long-term success in rapid recovery, high risk and revision therapy cases. The BioBoost Effect is the result of a proprietary combination of cancellous-like porosity and highly biocompatible tantalum. Through enhanced gene expression, the BioBoost Effect prompts early bone healing and attachment with a 2-week final loading protocol in appropriate cases, which has been documented to have a 97 to 100 percent survival rate after up to five years' follow-up. Clinical evidence also demonstrates the advantage of placing Trabecular Metal Implants in patients with risk factors such as diabetes, rheumatoid arthritis, prior oral infection, the effects of cancer treatment and poor bone quality. Additionally, because the BioBoost Effect supports the healthy ingrowth of vascularized bone as well as the potential for enhanced bone healing compared to conventional titanium implants, Trabecular Metal Implants may have a clinical advantage when used in revision therapy.1
"Although Trabecular Metal Technology has been used successfully in orthopedic applications for more than 20 years, its role in dentistry has been undervalued until now. Today, we have a wealth of clinical evidence supporting its growing role in dental implant therapy," said Indraneel Kanaglekar, Vice President, Global Product Management and R&D. "Uncovering a scientific explanation for the body's unique response to the Trabecular Metal Implant opens the door for our customers to treat a new subset of patients with a higher degree of confidence.
To take advantage of limited-time promotional offers or to receive a copy of the scientific compendium, contact a Zimmer Biomet sales representative by visiting www.zimmerbiometdental.com/findarep.
1 Data on file at Zimmer Biomet
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
Filed Under: Clinical, Implant Insights, Industry News, Press Releases